![]() |
市場調查報告書
商品編碼
1818029
2032年復健機器人市場預測:按產品類型、應用、最終用戶和地區進行的全球分析Rehabilitation Robotics Market Forecasts to 2032 - Global Analysis By Product Type (Therapeutic Robots, Exoskeletons, Assistive Robots, and Other Product Types), Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球康復機器人市場預計在 2025 年達到 5.0161 億美元,到 2032 年將達到 15.236 億美元,預測期內的複合年成長率為 17.2%。
復健機器人技術是指專注於設計、開發和實施機器人設備以協助患者在受傷、患病或神經病變後恢復身體能力的機器人技術領域。這些系統旨在透過提供一致、精確和重複的運動來支持運動學習和功能恢復,從而提高治療效果。復健機器人可用於上下肢訓練、步態輔助和認知運動康復,通常整合感測器和軟體,以根據患者的特定需求調整治療方案。作為傳統物理治療的補充,復健機器人可以改善患者的治療效果,減輕治療師的工作量,並提高患者在日常活動中的獨立性。
神經系統疾病增加
人工智慧設備正在提高治療的精準度和個人化。醫療保健提供者正在使用機器人技術來改善治療效果並減輕治療師的工作量。長期殘疾管理正在推動擴充性方案的需求。與臨床工作流程的整合正在擴大其在醫療保健領域的應用。這些趨勢正在強化機器人技術作為神經復健核心工具的地位。
對某些患者療效有限
缺乏標準化通訊協定和臨床結果參差不齊影響了醫護人員的信心。患者參與度和認知能力影響治療成功率。混合模式和個體化評估對於提高療效至關重要。長期數據有限,導致檢驗和報銷延遲。這些因素影響了不同臨床環境下的採用。
家庭醫療保健的採用率不斷提高
緊湊直覺的設備可支援遠端醫療和看護者的參與。與遠端醫療的整合正在改善可近性和監控。對減少醫院依賴的經濟實惠的解決方案的需求日益成長。模組化設計使居家慢性病護理支援成為可能。這些發展正在推動非臨床應用的成長。
發展中地區的可及性
設備昂貴和缺乏熟練人員限制了部署。醫療保健和醫學的碎片化降低了經濟可行性。文化和文化素養的挑戰影響了病人的參與度。改善醫療服務可近性和培訓需要各方共同努力。這些動態正在減緩全球市場的擴張。
新冠疫情對復健機器人市場產生了重大影響。醫療服務和選擇性手術的中斷減少了患者獲得機器人復健解決方案的機會。供應鏈中斷影響了機器人設備的製造和交付。然而,這場危機加速了人們對遠距和居家復健技術的興趣,並推動了遠距復健和自動化治療系統的創新。醫療保健提供者擴大尋求能夠最大程度減少直接接觸並確保患者護理連續性的解決方案,這凸顯了康復機器人領域的挑戰和新機會。
預計外骨骼細分市場將成為預測期內最大的細分市場
外骨骼領域預計將在預測期內佔據最大的市場佔有率,這得益於其在運動復健和步態訓練中的應用。其應用範圍涵蓋中風、脊髓損傷和整形外科復健。材料和感測器的進步正在提升其性能。它們在臨床和研究環境中的應用日益廣泛。需求涵蓋被動和主動系統。由於其治療用途的多樣性,預計該領域將繼續保持領先地位。
預計兒科復健領域在預測期內將以最高的複合年成長率成長
由於對早期療育和發展支持的日益重視,兒科復健領域預計將在預測期內實現最高成長率。機器人工具正針對腦性麻痹和肌肉萎縮症病症進行客製化。遊戲化介面和自適應回饋正在提升參與度。學校和診所正在投資兒童友善系統。研究和資金正在支持創新。隨著機器人技術在兒科醫療保健中的重要性日益凸顯,該領域必將迎來快速成長。
在預測期內,由於美國和加拿大擁有先進的醫療基礎設施和最尖端科技的廣泛應用,北美預計將佔據最大的市場佔有率。醫院和復健中心擴大採用治療機器人、外骨骼和上下肢輔助器具,以改善患者的復健效果。肌肉骨骼疾病、中風和神經系統疾病的盛行率不斷上升,推動了需求成長。政府措施和保險覆蓋範圍支持機器人輔助治療。科技新興企業與成熟醫療設備公司之間的合作,重點關注精準、安全和個人化的復健解決方案,將進一步促進市場成長。
由於老年人口不斷成長和慢性病盛行率不斷上升,預計亞太地區將在預測期內實現最高的複合年成長率。市場成長得益於政府醫療現代化計劃和醫療技術投資。外骨骼和穿戴式機器人設備在醫院和家庭護理機構中越來越受歡迎。本地公司正在創新經濟高效的解決方案,以應對可負擔性挑戰。宣傳宣傳活動和與國際公司的合作正在推動相關技術的普及,而技術進步則專注於提高患者在復健治療中的活動能力、靈活性和參與度。
According to Stratistics MRC, the Global Rehabilitation Robotics Market is accounted for $501.61 million in 2025 and is expected to reach $1523.6 million by 2032 growing at a CAGR of 17.2% during the forecast period. Rehabilitation robotics refers to the branch of robotics focused on designing, developing, and implementing robotic devices to assist individuals in recovering physical abilities after injury, illness, or neurological disorders. These systems aim to enhance the effectiveness of therapy by providing consistent, precise, and repetitive movements that support motor learning and functional recovery. Rehabilitation robots can be used for upper or lower limb training, gait assistance, and cognitive-motor rehabilitation, often integrating sensors and software to adapt therapy to the patient's specific needs. By complementing traditional physiotherapy, rehabilitation robotics improves patient outcomes, reduces therapist workload, and promotes independence in daily activities.
Rising incidence of neurological disorders
AI-enabled devices are improving therapy precision and personalization. Providers are using robotics to enhance outcomes and reduce therapist burden. Long-term disability management is increasing demand for scalable solutions. Integration with clinical workflows is expanding use across care settings. These trends are reinforcing robotics as a core tool in neurorehabilitation.
Limited effectiveness for certain patients
Lack of standardized protocols and mixed clinical results are affecting provider confidence. Patient engagement and cognitive capacity influence therapy success. Hybrid models and tailored assessments are needed to improve efficacy. Limited long-term data is slowing validation and reimbursement. These factors are impacting adoption in diverse clinical environments.
Increased adoption in home healthcare
Compact and intuitive devices support remote therapy and caregiver involvement. Telehealth integration is improving accessibility and monitoring. Demand is rising for affordable solutions that reduce hospital dependency. Modular designs are enabling chronic care support at home. These developments are driving growth in non-clinical applications.
Accessibility in developing regions
Equipment affordability and skilled personnel shortages limit deployment. Insurance and healthcare fragmentation reduces financial feasibility. Cultural and literacy challenges affect patient engagement. Collaborative efforts are needed to improve access and training. These dynamics are slowing global market expansion.
The COVID-19 pandemic significantly impacted the rehabilitation robotics market. Disruptions in healthcare services and elective procedures led to reduced patient access to robotic rehabilitation solutions. Supply chain interruptions affected the manufacturing and delivery of robotic devices. However, the crisis also accelerated interest in remote and home-based rehabilitation technologies, driving innovation in tele-rehabilitation and automated therapy systems. Healthcare providers increasingly sought solutions that minimize direct contact while ensuring continuous patient care, highlighting both challenges and emerging opportunities in the rehabilitation robotics sector.
The exoskeletons segment is expected to be the largest during the forecast period
The exoskeletons segment is expected to account for the largest market share during the forecast period due to their use in mobility restoration and gait training. Applications span stroke, spinal injury, and orthopedic recovery. Advances in materials and sensors are improving performance. Adoption is growing across clinical and research settings. Demand spans passive and active systems. This segment will continue to lead due to its therapeutic versatility.
The pediatric rehabilitation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pediatric rehabilitation segment is predicted to witness the highest growth rate due to emphasis on early intervention and developmental support. Robotic tools are being tailored for conditions like cerebral palsy and muscular dystrophy. Gamified interfaces and adaptive feedback are enhancing engagement. Schools and clinics are investing in child-friendly systems. Research and funding are supporting innovation. This segment is set for rapid growth as robotics becomes central to pediatric care.
During the forecast period, the North America region is expected to hold the largest market share by advanced healthcare infrastructure and high adoption of cutting-edge technologies in the United States and Canada. Hospitals and rehabilitation centers increasingly implement upper and lower limb therapy robots, exoskeletons, and assistive devices to improve patient outcomes. Rising prevalence of musculoskeletal disorders, stroke, and neurological conditions fuels demand. Government initiatives and insurance coverage support robotic-assisted therapies. Collaborations among tech startups and established medical device companies further strengthen market growth, emphasizing precision, safety, and personalized rehabilitation solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing geriatric populations and rising incidence of chronic diseases. Market growth is supported by government healthcare modernization programs and investments in medical technology. Exoskeletons and wearable robotic devices are gaining traction in hospitals and home-care settings. Local companies are innovating cost-effective solutions to meet the affordability challenge. Awareness campaigns and collaborations with international players are expanding adoption, while technological advancements focus on enhancing mobility, dexterity, and patient engagement in rehabilitation therapies.
Key players in the market
Some of the key players in Rehabilitation Robotics Market include Hocoma AG, ReWalk Robotics Ltd., Ekso Bionics Holdings Inc., Cyberdyne Inc., Bionik Laboratories Corp., Fourier Intelligence, Kinova Inc., Tyromotion GmbH, Rex Bionics Ltd., AlterG Inc., Wandercraft, Myomo Inc., Able Human Motion, Gogoa Mobility Robots and Bioness Inc.
In July 2025, Ekso Bionics announced a strategic distribution partnership with Bionic Prosthetics & Orthotics Group, marking its first channel for the Ekso Indego Personal device. This collaboration expands access to wearable exoskeletons across orthotics networks, targeting mobility-impaired individuals in outpatient and home settings.
In November 2023, ReWalk Robotics partnered with Israel's Human Robot Interaction Consortium under the MAGNET program to develop AI-enabled exoskeletons. The collaboration integrates advanced sensors and autonomous decision-making, allowing the device to adapt to terrain and reduce cognitive load for users.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.